Eli Lilly CEO on weight loss drugs outlook: Our top priority is making more product

Exclusive: How Eli Lilly’s making weight loss drugs more accessibleПодробнее

Eli Lilly CEO: We know there's high demand for weight-loss drugs and we're ready to meet itПодробнее

Eli Lilly CEO David Ricks on GLP-1 and obesity drugsПодробнее

Eli Lilly CEO talks expanding innovation past obesity drugsПодробнее

New developments in weight-loss drugs: Novo Nordisk, Eli Lilly & Pfizer advance studiesПодробнее

Potential for Weight-Loss Drugs Boosts Eli LillyПодробнее

Eli Lilly launches online direct-to-consumer pharmacy to help patients get weight loss drugsПодробнее

Eli Lilly CEO on Fighting Obesity, Developing New DrugsПодробнее

Eli Lilly goes direct-to-consumer on weight loss drugs: What patients and investors need to knowПодробнее

Former FDA commissioner: Expect more competition in Eli Lilly and Novo Nordisk's weight-loss drugsПодробнее

What is Zepbound? Weight loss drug now available, Eli Lilly saysПодробнее

Eli Lilly to Boost Obesity Drug Supply With Germany FactoryПодробнее

Eli Lilly releases new data from potentially game-changing weight loss drug trialПодробнее

Eli Lilly's weight-loss drug could be the best selling drug of all time, says Jim CramerПодробнее

Eli Lilly CEO on slashing insulin prices, approval timelines for weight-loss and Alzheimer's drugsПодробнее

I get stories every day from patients about how Mounjaro is benefiting their lives: Eli Lilly CEOПодробнее

Popular obesity drugs could be sold in pill form as soon as next year #shortsПодробнее

Eli Lilly goes direct-to-consumer on weight loss drugs #ShortsПодробнее

Vast utility for weight loss drugs will more than pay for themselves, says Eli Lilly CEO David RicksПодробнее